A Patient’s Guide to Clinical Trials
En Español | En Français
NIH Clinical Research Trials and You
Guidance regarding HIV anti-retroviral treatment in developing countries
Policy on Research Involving Human Subjects
NIAID is committed to advancing the understanding of how and why autoimmune diseases such as rheumatoid arthritis (RA) occur and to conduct clinical research studies to develop more effective treatment approaches and prevention strategies.
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis (ClinicalTrials.gov identifier NCT00837434)
The primary purpose of this study is to determine the effectiveness of two tumor necrosis factor (TNF) inhibitors, etanercept and adalimumab, on memory B lymphocytes (B cells) in the peripheral blood of participants with RA.
Read about Living with Arthritis by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
Last Updated March 09, 2012
Last Reviewed September 14, 2010